Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines.
第一作者:
G,Ishdorj
第一单位:
CancerCare Manitoba Research Institute (Formerly, Manitoba Institute of Cell Biology), University of Manitoba, Winnipeg, MB, Canada.
作者:
医学主题词
日常生活活动(Activities of Daily Living);腺嘌呤(Adenine);老年人(Aged);细胞因子类(Cytokines);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);男(雄)性(Male);试点项目(Pilot Projects);哌啶类(Piperidines);预后(Prognosis);前瞻性研究(Prospective Studies)
DOI
10.1016/j.leukres.2021.106628
PMID
34134067
发布时间
2021-11-29
- 浏览0
Leukemia research
106628页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



